Rapid risk assessment: Candida auris in healthcare settings – Europe

risk assessment
Cite:
Citation Link

 European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – first update, 23 April 2018. Stockholm: ECDC; 2018.

Copy citation to clipboard

This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries, considering the newly available information from the ECDC survey on the epidemiological situation as well as laboratory capacity and preparedness for C. auris in EU/EEA countries.

Related updates on healthcare-associated infections

Publication

ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level

technical guidance, protocol -

Publication

Communicable disease threats report, 8-14 July 2018, week 28

publication -

News

Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain

news -

Publication

Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain

risk assessment -

Publication

Clostridium difficile infections - Annual Epidemiological Report for 2016

surveillance report -